Regeneron Pharmaceuticals REGN has outperformed the market over the past 15 years by 21.17% on an annualized basis producing an average annual return of 27.88%. Currently, Regeneron Pharmaceuticals has a market capitalization of $80.91 billion.
Buying $100 In REGN: If an investor had bought $100 of REGN stock 15 years ago, it would be worth $3,995.69 today based on a price of $742.95 for REGN at the time of writing.
Regeneron Pharmaceuticals's Performance Over Last 15 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.